No published human RCT using ipamorelin or CJC-1295 specifically for body weight reduction in otherwise healthy adults with obesity has been registered on ClinicalTrials.gov with completed results as of this writing
The SURMOUNT-4 trial showed average regain of 14 percent of body weight within one year after stopping
Too much of the other, you gain weight there
The 2026 GRAPPA Annual Meeting and Trainee Symposium runs from July 9 to 11 at the Corinthia Lisbon
SIDE EFFECTS The most common adverse events reported in clinical trials for Cagrilintide, both as monotherapy and as CagriSema, are primarily gastrointestinal (GI) in nature, typically classified as mild to moderate in severity
Theyre easy to make, theyre easy to distribute, theyre easy to take, he says